Comparison of azapropazone and naproxen in rheumatoid arthritis

References

• Adrian R. W., Walker F. S., Noel P. R. B. Toxicological studies on azapropazone. Curr. Med. Res. Opin. 1976; 4: 171. Adrian R. W., Walker F. S., Noel P. R. B. Toxicological studies on azapropazone. Curr. Med. Res. Opin. 1976; 4: 17
   PubMedGoogle Scholar
• Beck E. R. Naproxen (Naprosyn) and gastro-intestinal haemorrhage. Br. Med. J. 1974; 1: 5722. Beck E. R. Naproxen (Naprosyn) and gastro-intestinal haemorrhage. Br. Med. J. 1974; 1: 572
   PubMedGoogle Scholar
• Brooks P. M., Mason D. I. R., McNeil R., Anderson J. A., Buchanan W. W. An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis. Curr. Med. Res. Opin. 1976; 4: 503. Brooks P. M., Mason D. I. R., McNeil R., Anderson J. A., Buchanan W. W. An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis. Curr. Med. Res. Opin. 1976; 4: 50
   PubMedGoogle Scholar
• Diamond H., Alexander S., Kuzell W., Lussier A., Odone D., Tompkins R. A multicentre double-blind crossover comparison of naproxen and aspirin in patients with rheumatoid arthritis. Scand. J. Rheumatol 1973; 2: 171, Suppl.4. Diamond H., Alexander S., Kuzell W., Lussier A., Odone D., Tompkins R. A multicentre double-blind crossover comparison of naproxen and aspirin in patients with rheumatoid arthritis. Scand. J. Rheumatol 1973; 2: 171, Suppl.
   Google Scholar
• Grennan D. M., McLeod M., Watkins C., Dick W. C. Clinical assessment of azapropazone in rheumatoid arthritis. Curr. Med. Res. Opin. 1976; 4: 445. Grennan D. M., McLeod M., Watkins C., Dick W. C. Clinical assessment of azapropazone in rheumatoid arthritis. Curr. Med. Res. Opin. 1976; 4: 44
   PubMedGoogle Scholar
• Hingorani K., Hicklin J. A., Templeton J. S., Lloyd K. J., Wilkinson M. A multi-centre study to compare the efficacy of azapropazone with indomethacin in the treatment of active early rheumatoid arthritis. To be published. 19756. Hingorani K., Hicklin J. A., Templeton J. S., Lloyd K. J., Wilkinson M. A multi-centre study to compare the efficacy of azapropazone with indomethacin in the treatment of active early rheumatoid arthritis. To be published. 1975
   Google Scholar
• Hart F. D. Naproxen (Naprosyn) and gastro-intestinal haemorrhage. Br. Med. J. 1974; 2: 517. Hart F. D. Naproxen (Naprosyn) and gastro-intestinal haemorrhage. Br. Med. J. 1974; 2: 51
   PubMed Web of Science ®Google Scholar
• Hill H. F. H., Hill A. g. S., Mowat A. g., Ansell B. M., Mathews J. A., Seifert M. H., Gumpel J. M., Christie G. A. Naproxen - a new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis. Ann. Rheum. Dis. 1974; 33: 128. Hill H. F. H., Hill A. g. S., Mowat A. g., Ansell B. M., Mathews J. A., Seifert M. H., Gumpel J. M., Christie g. A. Naproxen - a new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis. Ann. Rheum. Dis. 1974; 33: 12
   PubMed Web of Science ®Google Scholar
• Jahn U., Adrian R. W. Pharmakologische und toxikologische Prüfung des neuen Antiphlogisticums Azapropazon. Arzneim. Forsch. 1969; 19: 369. Jahn U., Adrian R. W. Pharmakologische und toxikologische Prüfung des neuen Antiphlogisticums Azapropazon. Arzneim. Forsch. 1969; 19: 36
   PubMedGoogle Scholar
• Jones C. J. The pharmacology and pharmacokinetics of azapropazone - a review. Curr. Med. Res. Opin. 1976; 4: 310. Jones C. J. The pharmacology and pharmacokinetics of azapropazone - a review. Curr. Med. Res. Opin. 1976; 4: 3
   PubMedGoogle Scholar
• Leader. Antirheumatic drugs: plenty is not enough. Br. Med. J. 1976; 1: 5911. Leader. Antirheumatic drugs: plenty is not enough. Br. Med. J. 1976; 1: 59
   PubMed Web of Science ®Google Scholar
• Lee P., Baxter A., Dick W. C., Webb J. An assessment of grip strength measurements in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 3: 1712. Lee P., Baxter A., Dick W. C., Webb J. An assessment of grip strength measurements in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 3: 17
   Web of Science ®Google Scholar
• Mintz G., Fraga A. Gastro-intestinal bleeding in patients with rheumatoid arthritis: the effects of azapropazone treatment. Curr. Med. Res. Opin. 1976; 4: 8913. Mintz g., Fraga A. Gastro-intestinal bleeding in patients with rheumatoid arthritis: the effects of azapropazone treatment. Curr. Med. Res. Opin. 1976; 4: 89
   PubMedGoogle Scholar
• Mintz G., Fraga A., Cervantes L., Cuarón A. Chronic salicylate induced gastro-intestinal bleeding. Quantitative response in therapy. Arthritis Rheum. 1970; 13: 33814. Mintz g., Fraga A., Cervantes L., Cuarón A. Chronic salicylate induced gastro-intestinal bleeding. Quantitative response in therapy. Arthritis Rheum. 1970; 13: 338
   Web of Science ®Google Scholar
• Nagai S. Therapeutic effect of azapropazone on chronic articular rheumatism. Paper read at 13th Congress of Japanese Rheumatic Society. 16–17 May, 196915. Nagai S. Therapeutic effect of azapropazone on chronic articular rheumatism. Paper read at 13th Congress of Japanese Rheumatic Society. 16–17 May, 1969
   Google Scholar
• Von Rechenberg H. K. Phenylbutazone, 2nd ed. Arnold, London 1962; 5416. Von Rechenberg H. K. Phenylbutazone, 2nd ed. Arnold, London 1962; 54
   Google Scholar
• Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. g., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med. 1968; 37: 39317. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. g., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med. 1968; 37: 393
   PubMedGoogle Scholar
• Ropes M. W., Bennett G. A., Cobb S., Jacox R., Jessar R. A. Revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum. 1959; 2: 1618. Ropes M. W., Bennett g. A., Cobb S., Jacox R., Jessar R. A. Revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum. 1959; 2: 16
   PubMed Web of Science ®Google Scholar
• Schatz F., Adrian R. W., Mixich G., Molnarova M., Reller J., Jahn U. Pharmakokinetische Untersuchungen mit dem Antiphlogistikum Azapropazon (Prolixan 300) am Menschen. Therapiewoche 1970; 20: 3919. Schatz F., Adrian R. W., Mixich g., Molnarova M., Reller J., Jahn U. Pharmakokinetische Untersuchungen mit dem Antiphlogistikum Azapropazon (Prolixan 300) am Menschen. Therapiewoche 1970; 20: 39
   Google Scholar
• Sugiyama T., Okazaki T., Onada T. Examination of medicinal effect of azapropazone in chronic articular rheumatism. J. Jap. Rheum. Ass. 1969; 9: 320. Sugiyama T., Okazaki T., Onada T. Examination of medicinal effect of azapropazone in chronic articular rheumatism. J. Jap. Rheum. Ass. 1969; 9: 3
   Google Scholar
• Thune S. A comparative study of azapropazone and indomethacin in the treatment of rheumatoid arthritis. Curr. Med. Res. Opin. 1976; 4: 7021. Thune S. A comparative study of azapropazone and indomethacin in the treatment of rheumatoid arthritis. Curr. Med. Res. Opin. 1976; 4: 70
   PubMedGoogle Scholar
• Webb J., Downie W. W., Dick W. C., Lee P. Evaluation of digital joint circumference measurements in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 12722. Webb J., Downie W. W., Dick W. C., Lee P. Evaluation of digital joint circumference measurements in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 127
   PubMedGoogle Scholar
• Willkens R. F. Double-blind crossover trial of naproxen and placebo in patients with rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 132, Suppl.23. Willkens R. F. Double-blind crossover trial of naproxen and placebo in patients with rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 132, Suppl.
   Google Scholar